Eurordis - Rare Disease Europe

This online course aims to raise awareness among patients and the engaging stakeholder organisations on the consequences that different patient engagement activities might have on patients. You will learn about best practices related to multi-stakeholder interactions and how each stakeholder could better manage competing interests, and help avoid/minimise conflict of interest by suggesting risk mitigation strategies.

This course is based on one of the main outcomes of the IMI-funded multi-stakeholder consortium PARADIGM (Patients active in research and dialogues for an improved generation of medicines). The Patient Engagement Toolbox centralises all PARADIGM’s co-created recommendations, tools and relevant background information to make patient engagement in medicines development easier for all. This course focuses on the specific guide: Raising awareness on managing competing interests in a multi-stakeholder environment: Guidance to patients and engaging stakeholders.

The first part covers general considerations applicable to all relevant stakeholders and the second part gives specific examples of patient and patient organisations, medicines developers and regulatory and HTA bodies.

At the end of some of the lessons, you’ll find a set of scenarios that will help you hone critical-thinking skills and apply the knowledge gained.

We would love to hear your feedback once you’ve completed the course. Go back to this page and submit your feedback using the ‘Feedback’ button that you’ll find below the progress bar. Your opinion is very valuable and will help us improve how we deliver our courses.